A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection

NCT02453789 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis
Burkholderia Infection

Interventions

DRUG: Alginate oligosaccharide
DRUG: Placebo

Sponsor

AlgiPharma AS